HONG KONG,Feb. 25,2025--Akeso,Inc. (9926.HK) ("Akeso" or the "Company") today announced that its partner on ivonescimab,Summit Therapeutics Inc. (NASDAQ: SMMT) has entered into a c
TOKYO,Feb. 25,2025-- GENERAL LINK Inc. has announced an exciting new campaign starting March 1st,2025,aimed at overseas travelers visiting Japan. The campaign will offer free optionsatGL Terrace, a lu
SHANGHAI,Feb. 25,2025-- ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057) ("ZTO" or the "Company"),a leading and fast-growing express delivery company inChina,today announced th
Per Narvinger,currently Head of Business Area Cloud Software and Services,is appointed Executive Vice President and new Head of Business Area Networks as of March 15,2025
New agreement spans packet core,signaling,charging & policy solutions STOCKHOLM,Feb. 25,2025-- India\'s Bharti Airtel and Ericsson (NASDAQ: ERIC) have strengthened their longstanding partnership t
Sugemalimab is the world\'s first anti-PD-L1 monoclonal antibody approved for the treatment of gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. The GEMSTONE-303 study results support sugem